药物基因组学

药物基因组学：预示了充满希望的未来以及回顾性的临床试验设计，FDA可能会为实现管理型决策的目的而批准后者。

Pharmacogenomics : Delivering on the Promise considers prospective versus retrospective clinical trial design and when , if ever , the FDA might allow the latter for regulatory decision-making purposes .

药物基因组学的应用及其市场前景

The Application and Marketing Prospect of Pharmacogenomics

这是本周NIH第二次宣布给药物基因组学项目提供资助。

This is the second announcement from the National Institutes of Health this week regarding funding for pharmacogenomics programs .

基因组上的SNP位点及其相应单体型的信息已经广泛地应用于疾病易感基因定位和药物基因组学研究。

SNPs and haplotypes in the human genome have been widely used in the identification of disease-associated genes and the study of pharmacogenomics .

昨天，NIH公布拨款1.61亿美元给，通过药物基因组学研究网络（PGRN）来关注药物和基因相互作用的许多大学和研究机构。

Yesterday , the NIH unveiled $ 161 million in new grants to a number of universities and institutes that will focus on drug and gene interactions through the Pharmacogenomics Research Network ( PGRN ) .

药物基因组学与合理用药研究进展

Advances of the study on pharmacogenomics and reasonable use of drugs

自行车设计开发的个性化思维药物基因组学&个性化药物的开发

Particular Thinking of Bicycle Development Pharmacogenomics & Design of Personalized Medicines

药物基因组学面临的挑战绝不是科学性的。

Not the least of the challenges facing pharmacogenomics is scientific .

麻醉药及其辅助药物基因组学的研究进展

Advances in research on pharmacogenomics of anesthetics and their adjuvants

药物基因组学：将基因组学应用于药物遗传学的学科。

Pharmacogenomics & The application of genomic information or methods to pharmacogenetic problems .

并展望药物基因组学的应用前景。

The prospect of its application was also forecast .

《国际循环》：药物基因组学对高血压预防和治疗策略有何影响？

International Circulation : How does pharmacogenomics affect hypertension prevention and treatment strategies ?

药物基因组学应用于临床药学是个体化用药的必然趋势

The application of pharmacogenomics in clinical pharmacy is the necessary path of individual medication

药物基因组学还可促进实现临床证据应用的个体化原则。

In addition , pharmacogenomics may promote the individualization of the clinical evidence application .

即便是生产和推广已经成功的药物基因组学产品的产家也在不断面临着困难。

Even companies manufacturing and marketing already successful pharmacogenomic drug-test combinations continue to face difficulties .

药物基因组学是研究遗传学与药物反应的相互关系。

Pharmacogenomics is defined as the study of the association between genetics and drug response .

药物基因组学能改进疟疾药物政策吗？

Can pharmacogenomics improve malaria drug policy ?

药物基因组学是一个非常困难的学科，并没有一个简单的答案可以概括之。

Pharmacogenomics is an extremely difficult business , one for which there are no easy answers .

药物基因组学在药动学研究中的应用

Application of Pharmacogenomics in Pharmacokinetic Study

药物基因组学对癌症化疗的启示

Pharmacogenomics : implication for cancer chemotherapy

药物基因组学在临床药物治疗学和新药开发中具有重要的意义。

Pharmacogenomics plays an important role in clinical pharmaceutics and new drug research and development . Clinical Study .

为了促进个体化用药的发展，笔者对药物基因组学的产生以及研究现况进行阐述。

To promote the development of personalized medicine , the author expounded the generation and present status of pharmacogenomics .

基因识别、基因治疗、基因药品以及药物基因组学渗透到了医学的每个角落。

Gene diagnosis , gene therapy , gene pharmacy , and pharmaceutical genomics have penetrated every corner of medicine .

本篇综述主要讨论当前和将来药物基因组学在临床癌症治疗和抗癌药物研制方面的应用。

This review discusses the current and future applications of pharmacogenomics in clinical cancer therapy and cancer drug development .

本文介绍了药物基因组学的概念、研究内容和方法及其在临床个体化用药中的应用及意义。

The article introduced the concept , content , methods of pharmacogenomics and its applications in establishing clinical individualized medication .

随着人们对人类基因组和人类基因组多样性研究的逐步深入，药物遗传学已发展到一个新的阶段-药物基因组学。

Along with the development of human genome project and human genome diversity research , pharmacogenomics is established from pharmacogenetics recently .

发现药物基因组学作为功能基因组学在医药学中的应用，能通过对基因多态性的研究，从根本上促进个体化用药的发展。

Pharmacogenomics essentially promote the development of personalized medicine by focus on the influence of human inherited polymorphism to the drug response .

药物基因组学帮助我们鉴定个性化药效反应的侧面信息，为同类个体选择最佳的治疗方案。

Pharmacogenomics allows us to identify sources of an individual 's profile of drug response and predict the best possible treatment option for this individual .

我们审查了在国家或区域范围内开发并实施以药物基因组学为指导治疗无并发症恶性疟疾政策的潜在障碍。

We review the potential hurdles to developing and implementing pharmacogenetic-guided policies at a national or regional scale for the treatment of uncomplicated falciparum malaria .

本文对基因芯片技术在药学研究（包括中药、药理毒理学和药物基因组学）的应用进行了综述。

Gene chip technology and its applications in pharmaceutical studies , including traditional Chinese medicine , pharmacology and toxicology and pharmacogenomics were reviewed in this paper .